Document Detail

The Novel UDP Glycosyltransferase 3A2: Cloning, Catalytic Properties, and Tissue Distribution.
MedLine Citation:
PMID:  21088224     Owner:  NLM     Status:  In-Data-Review    
The human UDP glycosyltransferase (UGT) 3A family is one of three families involved in the metabolism of small lipophilic compounds. Members of these families catalyze the addition of sugar residues to chemicals, which enhances their excretion from the body. The UGT1 and UGT2 family members primarily use UDP glucuronic acid to glucuronidate numerous compounds, such as steroids, bile acids, and therapeutic drugs. We showed recently that UGT3A1, the first member of the UGT3 family to be characterized, is unusual in using UDP N-acetylglucosamine as sugar donor, rather than UDP glucuronic acid or other UDP sugar nucleotides (J Biol Chem 283:36205-36210, 2008). Here, we report the cloning, expression, and characterization of UGT3A2, the second member of the UGT3 family. Like UGT3A1, UGT3A2 is inactive with UDP glucuronic acid as sugar donor. However, in contrast to UGT3A1, UGT3A2 uses both UDP glucose and UDP xylose but not UDP N-acetylglucosamine to glycosidate a broad range of substrates including 4-methylumbelliferone, 1-hydroxypyrene, bioflavones, and estrogens. It has low activity toward bile acids and androgens. UGT3A2 transcripts are found in the thymus, testis, and kidney but are barely detectable in the liver and gastrointestinal tract. The low expression of UGT3A2 in the latter, which are the main organs of drug metabolism, suggests that UGT3A2 has a more selective role in protecting the organs in which it is expressed against toxic insult rather than a more generalized role in drug metabolism. The broad substrate and novel UDP sugar specificity of UGT3A2 would be advantageous for such a function.
Peter I Mackenzie; Anne Rogers; David J Elliot; Nuy Chau; Julie-Ann Hulin; John O Miners; Robyn Meech
Related Documents :
8401174 - Bile acid inhibition of xenobiotic-metabolizing enzymes is a factor in the mechanism of...
16172874 - Taurine and cholestasis associated to tpn. experimental study in rabbit model.
19931294 - Upregulation of early growth response factor-1 by bile acids requires mitogen-activated...
17964214 - Effects of bile acids on expression of the human apical sodium dependent bile acid tran...
23164574 - Metabolic engineering of muconic acid production in saccharomyces cerevisiae.
6101134 - The roles of vitamin e and unsaturated fatty acids in the visual process.
Publication Detail:
Type:  Journal Article     Date:  2010-11-18
Journal Detail:
Title:  Molecular pharmacology     Volume:  79     ISSN:  1521-0111     ISO Abbreviation:  Mol. Pharmacol.     Publication Date:  2011 Mar 
Date Detail:
Created Date:  2011-02-21     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0035623     Medline TA:  Mol Pharmacol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  472-8     Citation Subset:  IM    
Department of Clinical Pharmacology, Flinders Medical Centre, Bedford Park, SA 5042, Australia.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Health benefits and cost-effectiveness of primary genetic screening for Lynch syndrome in the genera...
Next Document:  Different Effects of the Different Natural CC Chemokine Receptor 2b Ligands on {beta}-Arrestin Recru...